◢ A crisis is looming in Iran’s healthcare sector: patients are reporting shortages in life-saving medicine. The situation is expected to worsen once US sanctions on Iran are reimposed in November. European and US companies that can provide the advanced medicine and equipment needed to treat chronic diseases inside Iran are grappling with how to sustain their operations. New US sanctions will put the health of ordinary Iranians at risk. Europe can take concrete steps to minimize this—steps which also support its ongoing commitment to the nuclear deal.